Inventor · disambiguated record
Kirk Brown
Also filed as: BROWN KIRK · BROWN KIRK D · BROWN KIRK M
4 granted patents·13 pending applications·1 citations·filing 2005–2024
59Inventor score
Files withALNYLAM PHARMACEUTICALS INC12BROWN KIRK2BIOGEN MA INC1BRANDLE JAMES E1CA MINISTER AGRICULTURE & FOOD1
Top patents by PatentIndex Score
17 records- 0183US12005074B2Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2023·Granted Jun 11, 2024·0 cites·28 claims
- 0283US2024358738A1Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0382US11034957B2Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Jun 15, 2021·1 cites·30 claims
- 0476US2024200061A1TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0570US12397013B2Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Aug 26, 2025·0 cites·66 claims
- 0665US2022333104A1TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0763US2022002724A1AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0861US2024301418A1iRNA Compositions and Methods for Silencing Filamin A (FLNA)ALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0960US2025283079A1ACTIN-BINDING LIM PROTEIN 3 (ABLIM3) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1059US2023114649A1HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1156US2025011778A1APP iRNA Compositions and Methods of Use Thereof for Treating or Preventing Diseases Characterized by Enlarged EndosomesALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1255US2022307024A1Delivery of oligonucleotides to the striatumALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1345US2006168677A1Transcriptional termination of transgene expression using host genomic terminatorsCA MINISTER AGRICULTURE & FOOD·Filed 2005·Application pending·0 cites
- 1445US2008070276A1Transcriptional Termination of Transgene Expression Using Host Genomic TerminatorsBRANDLE JAMES E·Filed 2006·Application pending·0 cites
- 1542US2016041153A1Biomarker compositions and markersBROWN KIRK·Filed 2012·Application pending·0 cites
- 1642US2014220580A1Biomarker compositions and methodsBROWN KIRK·Filed 2012·Application pending·0 cites
- 1733US10662462B2Methods and compositions for detecting therapeutic nucleic acidsBIOGEN MA INC·Filed 2016·Granted May 26, 2020·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Kirk Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →